Debt conversion, converted instrument, shares

60,454,245

Company issued to Redstart a Convertible Promissory Note (the “Redstart Note”) in the aggregate principal amount of $153,600 for a purchase price of $128,000. The Redstart Note has a maturity date of November 3, 2021 and the Company has agreed to pay interest on the unpaid principal balance of the Redstart Note at the rate of six percent (6%) per annum from the date on which the Redstart Note is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise.

Debt conversion, converted instrument, Value

$ 50,000

$ 279,000

Extension fee

$ 1,000

Convertible debt decription

On or about June 23, 2020, the Company entered into agreements with SURG and Glen Eagles Acquisition LP (“Glen”) into series of agreements regarding the $4,000,000 SURG Note for which the SURG Note has been converted in full into 5,500,000 restricted stock of SURG (“Issued Shares”) along with an additional 22,000,000 SURG shares reserved for the benefit of the Company as a true up of shares to secure the value of the Issued Shares as $2,750,000. The Company agreed that the Issued Shares will be restricted for a year. As a result of the exchange of $2,750,000 of the SURG Note for 5,500,000 shares of SURG common stock, the Company recognized a loss of $1,430,000.

Subsequent Events (Details Narrative) - USD ($)		1 Months Ended		3 Months Ended	6 Months Ended
Subsequent Events (Details Narrative) - USD ($)	Aug. 04, 2020	Jun. 23, 2020	Jun. 20, 2020	Jun. 25, 2020	Jun. 30, 2020
Debt conversion, converted instrument, Value					$ 624,889
Debt conversion, converted instrument, shares					60,454,245
Subsequent Event [Member]
Convertible debt decription	Company issued to Redstart a Convertible Promissory Note (the “Redstart Note”) in the aggregate principal amount of $153,600 for a purchase price of $128,000. The Redstart Note has a maturity date of November 3, 2021 and the Company has agreed to pay interest on the unpaid principal balance of the Redstart Note at the rate of six percent (6%) per annum from the date on which the Redstart Note is issued (the “Issue Date”) until the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise.
Iliad [Member]
Debt conversion, converted instrument, Value				$ 50,000	$ 279,000
Debt conversion, converted instrument, shares				3,834,356
Extension fee			$ 1,000
Surge Holdings [Member]
Convertible debt decription		On or about June 23, 2020, the Company entered into agreements with SURG and Glen Eagles Acquisition LP (“Glen”) into series of agreements regarding the $4,000,000 SURG Note for which the SURG Note has been converted in full into 5,500,000 restricted stock of SURG (“Issued Shares”) along with an additional 22,000,000 SURG shares reserved for the benefit of the Company as a true up of shares to secure the value of the Issued Shares as $2,750,000. The Company agreed that the Issued Shares will be restricted for a year. As a result of the exchange of $2,750,000 of the SURG Note for 5,500,000 shares of SURG common stock, the Company recognized a loss of $1,430,000.